A HPLC-DAD method for the simultaneous determination of five marker components in the traditional herbal medicine Bangpungtongsung-sanmore suppliers
In Evidence-based Complementary and Alternative Medicine : eCAM, 2010
... (Santa Cruz, CA, USA), and ERK1/2, phospho-ERK1/2, JNK, phospho-JNK, p38, and phospho-p38 antibodies were purchased from Cell Signaling Technology, Inc ...
MAPK-Activated Protein Kinases (MKs): Novel Insights and Challenges.
More papers using
Hannover, Germany. In Front Cell Dev Biol, 2014
Downstream of MAPKs, such as classical/atypical ERKs and p38 MAPKs, but not of JNKs, signaling is often mediated by protein kinases which are phosphorylated and activated by MAPKs and, therefore, designated MAPK-activated protein kinases (MAPKAPKs).
Uncaria rhynchophylla induces heme oxygenase-1 as a cytoprotective effect in RAW 264.7 macrophages.
In PLoS ONE, 2009
... used; anti-Nrf2 (Santa Cruz Biotechnology, Santa Cruz, CA), anti-Lamin B (Santa Cruz), anti-HO-1 (Epitomics, Burlingame, CA), anti-phospho-p38 (Cell Signaling Technology, Beverly, MA), anti-phospho-PKC-δ ... The pivotal role of c-Jun NH2-terminal kinase-mediated Beclin 1 expression during anticancer agents-induced autophagy in cancer cells.
In PLoS ONE, 2008
... Anti-cleaved caspase3, anti-β-Actin, anti-phospho-P44/42 MAP Kinase, anti-P44/42 MAP Kinase, anti-SAPK/JNK, anti-phospho-SAPK/JNK, anti-p38MAP Kinase and anti-phospho-p38 MAP Kinase were from Cell Signaling Technology.Inc (CST, Danvers, Mass, ... Thrombospondin-1 enhances human thyroid carcinoma cell invasion through urokinase activity.
In PLoS ONE, 2007
... (9102), anti-SAPK/JNK (9252), anti-Akt (9272), anti-p38 (9212), anti-Src (32G6), anti-phospho-ERK-1/2 (9101), anti-phospho-SAPK/JNK (9251), anti-phospho-Akt (9271), anti-phospho-p38 (9211), HRP-conjugated anti-rabbit (7074) and specific MEK-1/2 inhibitor U0126 (9903) were from Cell Signaling Technology (distributed by Ozyme, ... Inhibition of breast tumor growth and angiogenesis by a medicinal herb: Ocimum gratissimum
In Evidence-based Complementary and Alternative Medicine : eCAM, 2006
... caspase-3, caspase-8, caspase-9, apaf-1, Bak, Bcl-2, phosphorylated-ERK1/2 (p-ERK1/2), ERK1/2, phosphorylated-JNK (p-JNK), JNK, phosphorylated-p38 (p-p38), and p38 were purchased from Cell Signaling Technologies (Beverly, MA) ... CD22 ligand binding regulates normal and malignant B lymphocyte survival in vivo
In Cancer Immunology, Immunotherapy, 2005
... IgG (H + L) Texas Red conjugate (Rockland Immunochemicals; Gilbertsville, PA), anti-phospho-JNK, anti-JNK, anti-phospho-ERK1/2, anti-ERK1/2, anti-phospho-p38, and anti-p38 antibodies (Cell Signaling Technology, Danvers, MA), anti-mouse ... Rapamycin inhibits cell motility by suppression of mTOR-mediated S6K1 and 4E-BP1 pathways.
In PLoS ONE, 2005
... were used for Western Blot: JNK1, phospho-JNK (Thr183/Tyr185), c-Jun, phospho-c-Jun (Ser63), ERK1/2, phospho-ERK1/2 (Thr202/Tyr204), p38, phospho-p38 (Thr180/Tyr182), that were provided from Santa Cruz Biotechnology, (Santa Cruz, CA, USA) ... Coordinate signaling by Src and p38 kinases in the induction of cortical cataracts
In Oncogene, 2003
... (Covance Research Products, Denver, PA), anti-MDA-9/syntenin polyclonal antibody (Alpha-Diagnostic International, San Antonio, TX), anti-p38 and anti-phospho-p38 (Cell Signaling, Beverly, MA), SB103580, PP2 ... p38 mitogen-activated protein kinase inhibitors-mechanisms and
In Mediators of Inflammation, 1998
... were from Santa Cruz Biotechnology, Inc, (Santa Cruz, Calif); and rabbit polyclonal phospho-JNK, phospho-Erk1/2, Erk1/2, phospho-p38, and p38 antibodies were from Cell Signaling Technology, Inc, (Beverly, Mass) ... Mitochondrial control of nuclear apoptosis
In Evidence-based Complementary and Alternative Medicine : eCAM, 1995
... Ras, Rho, Cdc42, ERK, JNK, p38, PKCα, PKCδ, and PKCε antibodies were purchased from BD Biosciences (San Diego, CA, USA) ...